Patent application number | Description | Published |
20090045367 | Circuit board for a Solenoid Valve Manifold - A circuit board ( | 02-19-2009 |
20090163574 | Stable Pharmaceutical Composition Containing Docetaxel and a Method of Manufacturing the Same - The present invention relates to a stable pharmaceutical composition for injection containing docetaxel and a method of preparing the same. More particularly, the present invention relates to a pharmaceutical composition for injection containing docetaxel having better storage stability than conventional medications, which is prepared by dissolving docetaxel, a water-insoluble compound, in distilled water after mixing it with cyclodextrin (CD) and a water-soluble polymer such as hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG) or polyvinylpyrrolidone (PVP) and lyophilizing the mixture, and a method of preparing the same. | 06-25-2009 |
20100069632 | SALTS OF PYRROLOPYRIMIDINONE DERIVATIVES AND PROCESS FOR PREPARING THE SAME - The present invention relates to salts of a pyrrolopyrimidinone derivative having superior PDE-5 inhibition activity and a process for preparing the same. More particularly, the present invention relates to a crystalline acid addition salt prepared by reacting a pyrrolopyrimidinone derivative with an acid selected from gentisic acid, maleic acid, citric acid, fumaric acid and tartaric acid. With no hygroscopic property and superior long-term storage stability, photostability and thermal stability, the salts of the pyrrolopyrimidinone derivative are appropriate to be prepared into medications and, with superior PDE-5 inhibition activity, are useful for the treatment and prevention of erectile dysfunction, pulmonary arterial hypertension, chronic obstructive pulmonary disease, benign prostatic hypertrophy and lower urinary tract diseases. | 03-18-2010 |
20100099773 | INCLUSION COMPLEX OF SIBUTRAMINE AND BETA-CYCLODEXTRIN - The present invention relates to a sibutramine-containing inclusion complex having superior storage stability, and particularly to a pharmaceutically stable inclusion complex suitable for the drug formulation, which prepared by reacting a sibutramine (N,N-dimethyl-1-[1-(4-chlorophenyl)-cyclobutyl]-3-methylbutylamine) of Formula 1 and beta-cyclodextrin in a predetermined ratio, its preparation method and a pharmaceutical composition comprising the same. | 04-22-2010 |
20100291243 | EXTRACTOR HAVING POTTERY WITH A DARK BROWN GLAZE AND THE METHOD FOR EXTRACTING USING THEREOF - Disclosed are an extractor having a “pottery with dark brown glaze” called “Onggi” in Korean, and a method of extracting using the same. The extractor includes a body, a body cover, a heating part, a pottery and a gas valve. The pottery is located within the body. The extractor extracts by injecting nitrogen gas, etc. into the body through a gas valve, thereby rendering the inside of the body to be high pressure state during extraction. Thus, the inside of the body is maintained under high pressure during extraction. Accordingly, an extract is located only within the pottery, and thus changes that can be caused while an extract contacts with the body can be prevented. | 11-18-2010 |
20100310485 | USE OF MELANIN BIOSYNTHESIS INHIBITORS FROM KOREAN GINSENG AND THE COSMETIC COMPOSITION CONTAINING THEREOF FOR SKIN WHITENING - Disclosed herein is a whitening cosmetic composition containing plant-derived ginsenoside Fl (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) as an active ingredient. More specifically, the ginsenoside Fl is obtained from particularly a ginseng extract using an acid, a base, an enzyme or microorganism, and a whitening cosmetic composition containing the ginsenoside Fl has an excellent effect of inhibiting melanin biosynthesis, and thus provides an excellent skin whitening effect. | 12-09-2010 |
20110014149 | COMPOSITION FOR SKIN EXTERNAL APPLICATION CONTAINING COMPLEX OF HERBAL EXTRACTS - Disclosed is a combination for skin external use, which contains as an active ingredient an herbal extract complex consisting of Chinese herbal extracts of Granate bark, seed of | 01-20-2011 |
20120267221 | HAPTIC STEERING WHEEL SWITCH APPARATUS AND HAPTIC STEERING WHEEL SWTICH SYSTEM INCLUDING THE SAME - The present invention provides a haptic steering wheel switch apparatus including: a haptic wheel housing unit configured to be disposed on a vehicle steering wheel; a circuit board unit configured to be disposed inside the haptic wheel housing unit; and a haptic wheel device including a haptic wheel device actuator configured to establish an electrical connection with the circuit board unit and including a haptic shaft, a haptic knob connected with the haptic shaft and exposedly disposed in the haptic wheel housing unit, and a haptic wheel device sensing unit configured to detect the rotating state of the haptic shaft, wherein the haptic wheel device is disposed on a front or rear side of the vehicle steering wheel, and a haptic steering wheel switch system including the same. | 10-25-2012 |
20130252247 | KIT FOR SCREENING FOR SKIN-ACTIVATING SUBSTANCES AND COMPRISING THE KLOTHO GENE, AND METHOD FOR SCREENING FOR SKIN-ACTIVATING SUBSTANCES USING THE SAME - The present invention relates to a kit for screening for skin-activating substances, and to a method for screening for skin-activating substances using same. More particularly, the present invention relates to a kit for screening for skin-activating substances and to a method for screening for skin-activating substances using same, in which candidates for inducing the expression of the klotho gene are separated from skin cells by the screening kit comprising the klotho gene, also known as the anti-aging gene, and the separated candidates are refined, thus screening for skin-activating substances such as moisturizing, anti-aging, or whitening substances. | 09-26-2013 |